[Design strategies and analysis techniques for real-world cancer research].
1/5 보강
With the development of precision medicine and big data technology, a large amount of medical data continues to accumulate, providing solid support for the application of real world study (RWS) in the
APA
Peng JJ, Tu HK (2025). [Design strategies and analysis techniques for real-world cancer research].. Zhonghua zhong liu za zhi [Chinese journal of oncology], 47(12), 1211-1218. https://doi.org/10.3760/cma.j.cn112152-20250724-00360
MLA
Peng JJ, et al.. "[Design strategies and analysis techniques for real-world cancer research].." Zhonghua zhong liu za zhi [Chinese journal of oncology], vol. 47, no. 12, 2025, pp. 1211-1218.
PMID
41443732 ↗
Abstract 한글 요약
With the development of precision medicine and big data technology, a large amount of medical data continues to accumulate, providing solid support for the application of real world study (RWS) in the field of cancer. Real world data (RWD) originates from clinical practice and can compensate for the limitations of randomized controlled trials, providing key evidence in the development of tumor prevention and control strategies, drug research and development, and medical insurance decisions. This article systematically reviews the design strategies of tumor RWS, including data source selection, research directions and research design types. It also delves into data analysis techniques such as data processing, statistical analysis methods, and bias control. In addition, this article summarizes the challenges currently faced by tumor RWS, such as data quality, privacy protection, and heterogeneity processing, and future development directions, such as artificial intelligence driven analysis and global collaboration. This article aims to provide methodological references for researchers and promote the standardized development of real world evidence (RWE).
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
같은 제1저자의 인용 많은 논문 (1)
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- A Phase I Study of Hydroxychloroquine and Suba-Itraconazole in Men with Biochemical Relapse of Prostate Cancer (HITMAN-PC): Dose Escalation Results.
- Self-management of male urinary symptoms: qualitative findings from a primary care trial.
- Clinical and Liquid Biomarkers of 20-Year Prostate Cancer Risk in Men Aged 45 to 70 Years.
- Diagnostic accuracy of Ga-PSMA PET/CT versus multiparametric MRI for preoperative pelvic invasion in the patients with prostate cancer.
- Association of patient health education with the postoperative health related quality of life in low- intermediate recurrence risk differentiated thyroid cancer patients.
- Early local immune activation following intra-operative radiotherapy in human breast tissue.